S&P 500   4,574.74 (+0.93%)
DOW   35,300.92 (+0.78%)
QQQ   370.41 (+1.07%)
AAPL   167.13 (+0.54%)
MSFT   308.78 (+1.80%)
FB   326.32 (+2.11%)
GOOGL   2,732.80 (+1.13%)
AMZN   3,146.30 (+0.65%)
TSLA   1,013.38 (+1.78%)
NVDA   252.26 (+0.63%)
BABA   135.22 (+5.86%)
NIO   29.89 (+4.40%)
AMD   125.94 (-1.82%)
CGC   7.97 (+4.32%)
MU   87.98 (-2.24%)
GE   100.28 (-0.34%)
T   27.04 (-0.88%)
F   21.73 (-3.21%)
DIS   151.26 (+0.77%)
AMC   18.29 (-0.16%)
PFE   53.29 (-0.47%)
ACB   5.00 (+2.88%)
BA   218.17 (+0.50%)
S&P 500   4,574.74 (+0.93%)
DOW   35,300.92 (+0.78%)
QQQ   370.41 (+1.07%)
AAPL   167.13 (+0.54%)
MSFT   308.78 (+1.80%)
FB   326.32 (+2.11%)
GOOGL   2,732.80 (+1.13%)
AMZN   3,146.30 (+0.65%)
TSLA   1,013.38 (+1.78%)
NVDA   252.26 (+0.63%)
BABA   135.22 (+5.86%)
NIO   29.89 (+4.40%)
AMD   125.94 (-1.82%)
CGC   7.97 (+4.32%)
MU   87.98 (-2.24%)
GE   100.28 (-0.34%)
T   27.04 (-0.88%)
F   21.73 (-3.21%)
DIS   151.26 (+0.77%)
AMC   18.29 (-0.16%)
PFE   53.29 (-0.47%)
ACB   5.00 (+2.88%)
BA   218.17 (+0.50%)
S&P 500   4,574.74 (+0.93%)
DOW   35,300.92 (+0.78%)
QQQ   370.41 (+1.07%)
AAPL   167.13 (+0.54%)
MSFT   308.78 (+1.80%)
FB   326.32 (+2.11%)
GOOGL   2,732.80 (+1.13%)
AMZN   3,146.30 (+0.65%)
TSLA   1,013.38 (+1.78%)
NVDA   252.26 (+0.63%)
BABA   135.22 (+5.86%)
NIO   29.89 (+4.40%)
AMD   125.94 (-1.82%)
CGC   7.97 (+4.32%)
MU   87.98 (-2.24%)
GE   100.28 (-0.34%)
T   27.04 (-0.88%)
F   21.73 (-3.21%)
DIS   151.26 (+0.77%)
AMC   18.29 (-0.16%)
PFE   53.29 (-0.47%)
ACB   5.00 (+2.88%)
BA   218.17 (+0.50%)
S&P 500   4,574.74 (+0.93%)
DOW   35,300.92 (+0.78%)
QQQ   370.41 (+1.07%)
AAPL   167.13 (+0.54%)
MSFT   308.78 (+1.80%)
FB   326.32 (+2.11%)
GOOGL   2,732.80 (+1.13%)
AMZN   3,146.30 (+0.65%)
TSLA   1,013.38 (+1.78%)
NVDA   252.26 (+0.63%)
BABA   135.22 (+5.86%)
NIO   29.89 (+4.40%)
AMD   125.94 (-1.82%)
CGC   7.97 (+4.32%)
MU   87.98 (-2.24%)
GE   100.28 (-0.34%)
T   27.04 (-0.88%)
F   21.73 (-3.21%)
DIS   151.26 (+0.77%)
AMC   18.29 (-0.16%)
PFE   53.29 (-0.47%)
ACB   5.00 (+2.88%)
BA   218.17 (+0.50%)
NASDAQ:VAXX

Vaxxinity News Headlines

$6.98
-0.96 (-12.09%)
(As of 01/20/2022 09:39 AM ET)
Add
Compare
Today's Range
$6.97
$7.88
50-Day Range
N/A
52-Week Range
$5.11
$22.77
Volume
1,091 shs
Average Volume
783,691 shs
Market Capitalization
$875.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Vaxxinity News Delivered to You Automatically

Sign up to receive the latest news and ratings for VAXX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Vaxxinity Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VAXX
News Sentiment

0.24

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VAXX Articles
This Week

9

2

VAXX Articles
Average Week



Vaxxinity (NASDAQ:VAXX) News Headlines Today

SourceHeadline
marketwatch.com logoVaxxinity Up 12%, Paused Twice Wednesday Morning
marketwatch.com - January 19 at 7:26 PM
MarketBeat logoVaxxinity (NASDAQ:VAXX) Sees Unusually-High Trading Volume
americanbankingnews.com - January 19 at 12:01 PM
MarketBeat logoVaxxinity (NASDAQ:VAXX) Shares Gap Up to $6.44
americanbankingnews.com - January 18 at 3:56 PM
MarketBeat logo Brokerages Anticipate Vaxxinity Inc (NASDAQ:VAXX) Will Announce Earnings of -$0.35 Per Share
americanbankingnews.com - January 17 at 10:16 AM
MarketBeat logoVaxxinity (NASDAQ:VAXX) Trading Down 9.3%
americanbankingnews.com - January 14 at 1:52 PM
finance.yahoo.com logoVaxxinity (VAXX) Starts Dosing in Parkinson's Disease Study
finance.yahoo.com - January 13 at 12:59 PM
MarketBeat logoVaxxinity (NASDAQ:VAXX) Shares Gap Down to $7.56
americanbankingnews.com - January 13 at 11:35 AM
reuters.com logoVaxxinity Inc
reuters.com - January 12 at 4:01 PM
MarketBeat logoVaxxinity (NASDAQ:VAXX) Shares Gap Up to $5.83
americanbankingnews.com - January 12 at 11:06 AM
finance.yahoo.com logoVaxxinity Announces First Parkinson’s Disease Patient Dosed in Part B of Phase 1 Clinical Trial of UB-312
finance.yahoo.com - January 12 at 10:59 AM
finance.yahoo.com logoVaxxinity Awarded Grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to Support UB-312 Vaccine Study
finance.yahoo.com - January 10 at 8:22 AM
finance.yahoo.com logoVaxxinity Appoints Jason Pesile as SVP, Finance & Accounting, and George Hornig to Board of Directors
finance.yahoo.com - January 4 at 8:05 AM
MarketBeat logoVaxxinity Inc (NASDAQ:VAXX) Expected to Announce Earnings of -$0.34 Per Share
americanbankingnews.com - December 28 at 12:10 PM
finance.yahoo.com logoVaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
finance.yahoo.com - December 23 at 7:06 PM
finance.yahoo.com logoVaxxinity, Backblaze Shares Gain in Debuts, but 3 Other IPOs Drop
finance.yahoo.com - December 2 at 9:49 PM
finance.yahoo.com logoVaxxinity Insider Makes $240K Stock Purchase
finance.yahoo.com - December 2 at 9:49 PM
finance.yahoo.com logoVaxxinity Announces Closing of IPO and Partial Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 2 at 9:49 PM
finance.yahoo.com logoVaxxinity Has a Rough Public Debut
finance.yahoo.com - December 2 at 9:49 PM
Get Vaxxinity News Delivered to You Automatically

Sign up to receive the latest news and ratings for VAXX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.